Neotis
1 known investors
Find your way into Neotis
645 people in our graph share verified history with the Neotis team — schools, employers, funds. One of them is your warm intro.
Erica Vanunlockedknows Cathal Meehan, PhD · together at Stealth Startup (overlapped)
×6knows the team · via Stealth Startup
×2knows the team · via Harvard Business School
×2knows the team · via Trinity College Dublin
knows the team · via Cold Spring Harbor Laboratory
Neotis develops immunotherapies to counteract age-related tissue decline by directing the immune system, with an initial focus on fibrotic disease. The company combines expertise in immunology, senescence, and biomarker development.
Founders & leadership
CM
Cathal Meehan, PhDinCEOCathal Meehan holds a PhD in bioinformatics from the University of Warwick, with research focused on plant genomics and crop improvement, and has held roles in diagnostics development and biomarker discovery at Paris-based biotech firms before co-founding Neotis as CEO.
MS
Michael Saitakis, PhDCSO
Investors · 1
Competitors · 1
by search overlap
Companies competing with Neotis for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Neotis do?
- Neotis develops immunotherapies to counteract age-related tissue decline by directing the immune system, with an initial focus on fibrotic disease. The company combines expertise in immunology, senescence, and biomarker development.
- Who are Neotis's investors?
- Neotis's investors include Daphni.